Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

The role of calcium and calcium antagonists in the reperfusion injury of the heart

Thesis (PhD)--Stellenbosch University, 2005.

Saved in:
Bibliographic Details
Main Author: Conradie, Suzanne Louise
Other Authors: Coetzee, A. (Andre)
Format: Thesis
Language:en_ZA
Published: Stellenbosch : Stellenbosch University 2012
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613951565496320
access_status_str Open Access
author Conradie, Suzanne Louise
author2 Coetzee, A. (Andre)
author_browse Coetzee, A. (Andre)
Conradie, Suzanne Louise
author_facet Coetzee, A. (Andre)
Conradie, Suzanne Louise
author_sort Conradie, Suzanne Louise
collection Thesis
dc_rights_str_mv Stellenbosch University
description Thesis (PhD)--Stellenbosch University, 2005.
format Thesis
id oai:scholar.sun.ac.za:10019.1/50518
institution Stellenbosch University (South Africa)
language en_ZA
last_indexed 2026-06-10T12:44:18.274Z
license_str Other — see source repository
provenance_str_mv Harvested via OAI-PMH from SUNScholar — Stellenbosch University Repository
publishDate 2012
publishDateRange 2012
publishDateSort 2012
publisher Stellenbosch : Stellenbosch University
publisherStr Stellenbosch : Stellenbosch University
record_format dspace
source_str SUNScholar — Stellenbosch University Repository
spelling oai:scholar.sun.ac.za:10019.1/50518 The role of calcium and calcium antagonists in the reperfusion injury of the heart Conradie, Suzanne Louise Coetzee, A. (Andre) Moolman, J. (Johan) Coetzee, J. (Johan) Stellenbosch University. Faculty of Medicine and Health Sciences. Dept. of Interdisciplinary Health Sciences. Emergency Medicine. Reperfusion injury -- Treatment Myocardial reperfusion -- Treatment Coronary heart disease -- Treatment Calcium -- Antagonists -- Therapeutic use Verapamil Dissertations -- Emergency medicine Theses -- Emergency medicine Thesis (PhD)--Stellenbosch University, 2005. ENGLISH ABSTRACT: The reperfusion injury after myocardial ischemia is relevant in the clinical setting, after cardiopulmonary bypass for cardiac surgery, after PTCA and stenting and after cardiopulmonary resuscitation. The components of the reperfusion injury considered in this study were myocardial stunning and reperfusion arrhythmias. Calcium antagonists have been shown to be beneficial in attenuating the myocardial reperfusion injury in the in vitro and in vivo laboratory setting (Lamping, Gross 1985, Przyklenk and Kloner 1988, Taylor 1990, Ehring 1992, Gross and Piper 1992). However systemic administration of a dose of calcium antagonist, large enough to attenuate the myocardial reperfusion injury in the clinical setting, would inevitably lead to unwanted systemic side effects of the drug. The aim of this study was to investigate the hypothesis that an adequate dose of verapamil administered timeously, directly into the ischemic myocardium, would attenuate the reperfusion injury, either when administered from the onset of ischemia, or from 3 minutes before reperfusion. The anesthetized open chest porcine model of myocardial ischemia (15 min total LAD occlusion) and reperfusion was employed in this study. A low dose of verapamil (0.5 mg/8mt or 0.0625mg/mt), a high dose of verapamil (2mg/8m or O.25mg/ml), or vehicle (saline) (8ml) was infused over 8 minutes, directly into the LAD coronary artery supplying the ischemic segment. The infusion was started either at the onset of ischemia, or from 3 minutes before reperfusion. The time taken for the various parameters to return to pre ischemic values was compared between the different groups. The results showed that the high dose of verapamil (2mg) attenuated the reperfusion injury both when administered from the onset of ischemia, and when administered from 3 minutes before reperfusion, compared to either the low dose of verapamil, or the saline infusions. The high dose of verapamil groups had a faster recovery of both systolic contractile function and diastolic function and a lower incidence of ventricular fibrillation on reperfusion. There were no systemic effects of verapamil infusion in any of the groups. The clinical setting of cardiac surgery expressly lends itself to the clinical application of this finding. There is direct access to the coronary arteries both before ischemia and before reperfusion. A small dose of calcium channel blocking drug, with no systemic effect can be administered into the aortic root at the onset of ischemia, just prior to cardioplegia (when the heart is still warm), and after rewarming a few minutes prior to removal of the aortic cross clamp. AFRIKAANSE OPSOMMING: Die reperfusie besering na miokardiale isgemie is klinies relevant na kardiopulmonêre omleiding vir hart chirurgie, na kardiologiese PTKA en stut prosedures en na kardiopulmonale ressussitasie. Die komponente van die reperfusie besering wat in hierdie studie oorweeg is, is miokardiale tydelike omkeerbare onderdrukking (stunning) en reperfusie arritmieë. Kalsium antagoniste is gewys om effektief te wees in beperking van die reperfusie besering in beide in vitro en in vivo laboratorium eksperimente (Lamping, Gross 1985, Przyklenk en Kloner 1988, Taylor 1990, Ehring 1992, Gross en Piper 1992). Sistemiese toediening van 'n dosis kalsium kanaal blokker, voldoende om die miokardiale reperfusie besering in die pasiënt te beperk, lei egter tot ongewenste sistemiese newe effekte van die middel. Die doel van die studie was om die hipotese te ondersoek dat 'n voldoende dosis verapamil, wat betyds direk toegedien is aan die isgemiese miokardium, die reperfusie besering sal beperk, ongeag of dit toegedien is vanaf die begin van isgemie, of van 3 minute voor reperfusie. Die vark model van miokardiale isgemie en reperfusie is aangewend in die studie. Die varke was tydens die eksperiment onder narkose, met die borskas oop, en 15 minute totale LAD okklusie is toegepas. 'n Lae dosis verapamil (0.5mg/8ml of 0.0625 mg/mt), of hoë dosis veraparnil (2mg/8mt of 0.25mg/mt), of saline (8mt) is oor 8 minute toegedien direk in die LAD arterie wat die isgemiese segment voorsien. Die infuus is begin direk na die aanvang van isgemie, of 3 minute voor die aanvang van reperfusie. Die tyd geneem vir terugvoer van parameters na pre isgemiese waardes is tussen die groepe vergelyk. Die resultate toon dat die hoë dosis veraparnil die reperfusie besering beperk in vergelyking met die lae dosis veraparnil of saline infusies, ongeag of dit van die begin van isgemie, of van 3 minute voor reperfusie toegedien word. Die groepe wat die hoë dosis veraparnil ontvang het, het vinniger herstel van sistoliese en diastoliese funksie getoon en het'n laer insidensie van reperfusie disritmieë, gewys. Geen sistemiese effekte van veraparnail infuus is waargeneem nie. Die kliniese toepassing van hierdie bevinding is by uitstek geskik vir toepassing tydens kardiopulmonale omleiding by kardiale chirurgie. Daar is direkte toegang tot koronêre arteries voor isgemie en voor reperfusie. 'n Klein dosis kalsium antagonis, met weglaatbare sistemiese effekte, kan toegedien word in die aorta wortel met die aanvang van isgemie, net voor kardioplegie toediening (hart steeds warm), en na verwarming, 'n paar minute voor verwydering van die aorta kruis klem. Doctoral 2012-08-27T11:33:27Z 2012-08-27T11:33:27Z 2005 Thesis http://hdl.handle.net/10019.1/50518 en_ZA Stellenbosch University 291 p. : ill. application/pdf Stellenbosch : Stellenbosch University
spellingShingle Reperfusion injury -- Treatment
Myocardial reperfusion -- Treatment
Coronary heart disease -- Treatment
Calcium -- Antagonists -- Therapeutic use
Verapamil
Dissertations -- Emergency medicine
Theses -- Emergency medicine
Conradie, Suzanne Louise
The role of calcium and calcium antagonists in the reperfusion injury of the heart
title The role of calcium and calcium antagonists in the reperfusion injury of the heart
title_full The role of calcium and calcium antagonists in the reperfusion injury of the heart
title_fullStr The role of calcium and calcium antagonists in the reperfusion injury of the heart
title_full_unstemmed The role of calcium and calcium antagonists in the reperfusion injury of the heart
title_short The role of calcium and calcium antagonists in the reperfusion injury of the heart
title_sort role of calcium and calcium antagonists in the reperfusion injury of the heart
topic Reperfusion injury -- Treatment
Myocardial reperfusion -- Treatment
Coronary heart disease -- Treatment
Calcium -- Antagonists -- Therapeutic use
Verapamil
Dissertations -- Emergency medicine
Theses -- Emergency medicine
url http://hdl.handle.net/10019.1/50518
work_keys_str_mv AT conradiesuzannelouise theroleofcalciumandcalciumantagonistsinthereperfusioninjuryoftheheart
AT conradiesuzannelouise roleofcalciumandcalciumantagonistsinthereperfusioninjuryoftheheart